Benzinga’s Top Pre-Market Gainers (PVH, AMLN, CHRD, ISIS, NVAX)
March 15, 2010 8:26 AM
Phillips-Van Heusen Corporation (NYSE: PVH) increased 7.35% to $51.25 in the pre-market session. Phillips-Van Heusen announced a definitive agreement for PVH to acquire Tommy Hilfiger B.V., which is controlled by funds affiliated with Apax Partners L.P., for total consideration of EUR2.2 billion (approximately $3.0 billion) plus the assumption of EUR100 million in liabilities. The 52-week trading range for PVH is $16.38 - $48.78. In the last six months, PVH has gained over 14%.
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) climbed 13.03% to $22.90 in the pre-market session. Amylin Pharmaceuticals, Inc., Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration has issued a complete response letter regarding the New Drug Application for BYDUREON (exenatide for extended-release injectable suspension). In the previous trading session, AMLN closed at $20.26. AMLN has surged over 80% in the last year.
Chordiant Software, Inc. (NASDAQ: CHRD) jumped 31.23% to $3.81 in the pre-market session. Pegasystems Inc. (NASDAQ: PEGA) and Chordiant Software, Inc. announced they have entered into a definitive agreement for Pegasystems to acquire Chordiant. The 52-week trading range for CHRD is $2.31 - $4.32. CHRD closed at $3.81 in the last trading session.
ISIS Pharmaceuticals, Inc. (NASDAQ: ISIS) moved up 3.20% to $10 in the pre-market session. The 52 week trading range for ISIS is $8.59 -$18.81. ISIS closed at $9.69 in the previous trading session. ISIS has declined over 38% in the last six months.
Novavax, Inc. (NASDAQ: NVAX) surged 4.29% to $2.43 in the pre-market session. In the last trading session, NVAX closed at $2.33. The 52-week trading range for NVAX is $0.52 - $7.79.
